{
    "root": "1f2a8fc9-461e-4e33-9a00-81caf2fcd973",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Paliperidone",
    "value": "20250130",
    "ingredients": [
        {
            "name": "PALIPERIDONE",
            "code": "838F01T721",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_82978"
        },
        {
            "name": "BUTYLATED HYDROXYTOLUENE",
            "code": "1P9D0Z171K",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_24751"
        },
        {
            "name": "CELLULOSE ACETATE",
            "code": "3J2P07GVB6",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_145232"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (20000 WAMW)",
            "code": "KZQ570MOA5",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00840"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYETHYLENE OXIDE 200000",
            "code": "11628IH70O",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25741"
        },
        {
            "name": "POLYETHYLENE OXIDE 7000000",
            "code": "G3MS6M810Y",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25741"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "indications": {
        "text": "paliperidone extended-release tablets atypical antipsychotic agent indicated treatment schizophrenia ( 1.1 ) adults : efficacy established three 6-week trials one maintenance trial . ( 14.1 ) adolescents ( ages 12 17 ) : efficacy established one 6-week trial . ( 14.1 ) treatment schizoaffective disorder monotherapy adjunct mood stabilizers and/or antidepressants . ( 1.2 ) efficacy established two 6-week trials adult patients . ( 14.2 )",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            },
            {
                "text": "schizoaffective disorder (DOID:5418)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5418"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "initial dose recommended dose maximum dose schizophrenia \u2013 adults ( 2.1 ) 6 mg/day 3 mg/day 12 mg/day 12 mg/day schizophrenia- adolescents ( 2.1 ) weight < 51 kg 3 mg/day 3 mg/day 6 mg/day 6 mg/day weight \u2265 51 kg 3 mg/day 3 mg/day 12 mg/day 12 mg/day schizoaffective disorder - adults ( 2.2 ) 6 mg/day 3 mg/day 12 mg/day 12 mg/day tablet swallowed whole chewed , divided , crushed . ( 2.3 )",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            },
            {
                "text": "schizoaffective disorder (DOID:5418)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5418"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "known hypersensitivity paliperidone , risperidone , excipients paliperidone extended-release tablets . ( 4 )",
    "indications_original": "Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for Treatment of schizophrenia ( 1.1 ) Adults: Efficacy was established in three 6-week trials      and one maintenance trial. ( 14.1 ) Adolescents (ages 12 to 17): Efficacy was established in      one 6-week trial. ( 14.1 ) Treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressants. ( 1.2 ) Efficacy was established in two 6-week trials in adult      patients. ( 14.2 )",
    "contraindications_original": "Initial Dose Recommended Dose Maximum Dose Schizophrenia \u2013 adults ( 2.1 ) 6 mg/day 3 mg/day to 12 mg/day 12 mg/day Schizophrenia- adolescents ( 2.1 ) Weight < 51 kg 3 mg/day 3 mg/day to 6 mg/day 6 mg/day Weight \u2265 51 kg 3 mg/day 3 mg/day to 12 mg/day 12 mg/day Schizoaffective disorder - adults ( 2.2 ) 6 mg/day 3 mg/day to 12 mg/day 12 mg/day Tablet should be swallowed whole and should not be chewed, divided, or crushed. ( 2.3 )",
    "adverseReactions_original": "Known hypersensitivity to paliperidone, risperidone, or to any excipients in paliperidone extended-release tablets. ( 4 )",
    "drug": [
        {
            "name": "Paliperidone",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_82978"
        }
    ]
}